FEBUXOSTAT
- Product NDC
- 72303-0856
- 11-digit product format
- 723030856
- Labeler code
- 72303
- Product ID
- 72303-0856_4f1d0d50-8032-d895-e063-6394a90a9bb8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- febuxostat
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- HEC Pharm USA Inc.
- Application
- ANDA213069
- Marketing category
- ANDA
- Marketing start
- 2026-04-10
- Substance
- FEBUXOSTAT
- Active strength
- 80 mg/1
- Pharmacologic classes
- Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 101V0R1N2E | FEBUXOSTAT | 144060-53-7 | FEBUXOSTAT |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72303-0856-1 | 72303085601 | 30 TABLET in 1 BOTTLE (72303-0856-1) | 30 tablet | 2026-04-10 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| FEBUXOSTAT | HEC Pharm USA Inc. | Sunshine Lake Pharma Co., Ltd. | 2026-03-10 | HUMAN PRESCRIPTION DRUG LABEL | 1 |